Vedolizumab, adalimumab and methotrexate combination in CD
Vedolizumab in children with IBD
Phase 2 trial, guselkumab in Crohn’s disease efficacy and safety at week 48
Adalimumab increased interval in CD
LAG-3 depleting antibody GSK2831781 in UC
Mirikizumab induction and maintenance
Mercaptopurine in UC for maintenance
Mediterranean Diet vs Canadian diet in quiescent UC
Olamkicept induction in ulcerative colitis
Over-the-Counter Multivitamin and Mineral Supplement to Prevent Infections in IBD Patients